1. Home
  2. PGEN vs TRS Comparison

PGEN vs TRS Comparison

Compare PGEN & TRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Precigen Inc.

PGEN

Precigen Inc.

HOLD

Current Price

$4.20

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Logo TriMas Corporation

TRS

TriMas Corporation

HOLD

Current Price

$35.62

Market Cap

1.5B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
PGEN
TRS
Founded
1998
1986
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Specialties
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.5B
IPO Year
N/A
2007

Fundamental Metrics

Financial Performance
Metric
PGEN
TRS
Price
$4.20
$35.62
Analyst Decision
Buy
Strong Buy
Analyst Count
5
2
Target Price
$7.67
$41.50
AVG Volume (30 Days)
5.0M
612.5K
Earning Date
11-13-2025
10-28-2025
Dividend Yield
N/A
0.44%
EPS Growth
N/A
68.70
EPS
N/A
1.08
Revenue
$6,309,000.00
$1,013,740,000.00
Revenue This Year
$342.78
$11.57
Revenue Next Year
$478.46
N/A
P/E Ratio
N/A
$33.29
Revenue Growth
59.20
11.83
52 Week Low
$0.76
$19.33
52 Week High
$5.23
$40.34

Technical Indicators

Market Signals
Indicator
PGEN
TRS
Relative Strength Index (RSI) 54.86 59.39
Support Level $4.05 $35.41
Resistance Level $4.53 $36.26
Average True Range (ATR) 0.29 0.71
MACD 0.05 0.20
Stochastic Oscillator 69.99 77.78

Price Performance

Historical Comparison
PGEN
TRS

About PGEN Precigen Inc.

Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.

About TRS TriMas Corporation

TriMas Corp designs, develops and manufactures a diverse set of products primarily for the consumer products, aerospace & defense, and industrial markets . The company operates through three segments namely: The packaging segment manufactures and distributes closure and dispensing systems. The aerospace segment supplies blind bolts, fasteners, rivets, and other products for the aerospace industry. The specialty product segment manufactures and distributes steel cylinders, wellhead engines, compression systems, industrial sealing, and fasteners.

Share on Social Networks: